Erica O’Bryan
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
-
- Neuropeptides and Animal Physiology
Papers in
-
- Cell death mechanisms and regulation 3
- Heat shock proteins research 1
- Retinoids in leukemia and cellular processes 1
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Kapil N. Bhalla (7 shared papers)Ramadevi Nimmanapalli (7 shared papers)Nigel W. Bunnett (1 shared paper)Kathryn DeFea (1 shared paper)Olivier Déry (1 shared paper)Purva Bali (3 shared papers)Hong‐Gang Wang (2 shared papers)Fei Guo (2 shared papers)
- Journals
- Blood (2 papers)Clinical Cancer Research (1 paper)Journal of Immunological Methods (1 paper)Proceedings of the National Academy of Sciences (1 paper)PubMed (3 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Erica O’Bryan
7 papers receiving 913 citations
Peers
Comparison fields: 5 of 74
- Hematology 186
- Cellular and Molecular Neuroscience 206
- Genetics 107
- Molecular Biology 680
- Rheumatology 70
Countries citing papers authored by Erica O’Bryan
This map shows the geographic impact of Erica O’Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica O’Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica O’Bryan more than expected).
Fields of papers citing papers by Erica O’Bryan
This network shows the impact of papers produced by Erica O’Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica O’Bryan. The network helps show where Erica O’Bryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Erica O’Bryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 332 | |
| 2 | Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. | 2001 | 216 |
| 3 | 2002 | 136 | |
| 4 | Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin. | 2002 | 91 |
| 5 | 2003 | 80 | |
| 6 | Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. | 2003 | 43 |
| 7 | 2004 | 33 | |
| 8 | 2019 | 0 |
About Erica O’Bryan
Erica O’Bryan is a scholar working on Molecular Biology, Genetics, Hematology, Oncology and Cancer Research, having authored 8 papers that have together received 931 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Cell death mechanisms and regulation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), NF-κB Signaling Pathways (2 papers), Heat shock proteins research (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Retinoids in leukemia and cellular processes (1 paper). The work is most often cited by research in Hematology (186 citations), Cellular and Molecular Neuroscience (206 citations), Genetics (107 citations), Molecular Biology (680 citations) and Rheumatology (70 citations). Erica O’Bryan has collaborated with scholars based in United States and Canada. Frequent co-authors include Kapil N. Bhalla, Ramadevi Nimmanapalli, Nigel W. Bunnett, Kathryn DeFea, Olivier Déry, Purva Bali, Hong‐Gang Wang, Fei Guo, Shanthi R. Paranawithana and David Griffin. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Immunological Methods, Proceedings of the National Academy of Sciences and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.